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Biocompatibility of two Experimental Scaffolds for Regenerative Endodontics 
Abstract 
Objectives 
The biocompatibility of two experimental scaffolds for potential use in revascularization or pulp 
regeneration was evaluated. 
Materials and Methods 
One resilient lyophilized collagen scaffold (COLL), releasing metronidazole and clindamycin, was 
compared to an experimental injectable poly(lactic-co-glycolic) acid scaffold (PLGA), releasing 
clindamycin. Human dental pulp stem cells (hDPSCs) were seeded at densities of 1.0 × 104, 2.5 × 104, and 
5.0 × 104. The cells were investigated by light microscopy (cell morphology), MTT assay (cell 
proliferation) and a cytokine (IL-8) ELISA test (biocompatibility). 
Results 
Under microscope, the morphology of cells coincubated for 7 days with the scaffolds appeared healthy 
with COLL. Cells in contact with PLGA showed signs of degeneration and apoptosis. MTT assay showed 
that at 5.0 × 104 hDPSCs, COLL demonstrated significantly higher cell proliferation rates than cells in 
media only (control, p < 0.01) or cells co-incubated with PLGA (p < 0.01). In ELISA test, no significant 
differences were observed between cells with media only and COLL at 1, 3, and 6 days. Cells incubated 
with PLGA expressed significantly higher IL-8 than the control at all time points (p < 0.01) and compared 
to COLL after 1 and 3 days (p < 0.01). 
Conclusions 
The COLL showed superior biocompatibility and thus may be suitable for endodontic regeneration 
purposes. 
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Biocompatibility of two experimental scaffolds for 
regenerative endodontics
Objectives: The biocompatibility of two experimental scaffolds for potential use in 
revascularization or pulp regeneration was evaluated. Materials and Methods: One 
resilient lyophilized collagen scaffold (COLL), releasing metronidazole and clindamycin, 
was compared to an experimental injectable poly(lactic-co-glycolic) acid scaffold 
(PLGA), releasing clindamycin. Human dental pulp stem cells (hDPSCs) were seeded 
at densities of 1.0 x 104, 2.5 x 104, and 5.0 x 104. The cells were investigated by light 
microscopy (cell morphology), MTT assay (cell proliferation) and a cytokine (IL-8) 
ELISA test (biocompatibility). Results: Under microscope, the morphology of cells co-
incubated for 7 days with the scaffolds appeared healthy with COLL. Cells in contact 
with PLGA showed signs of degeneration and apoptosis. MTT assay showed that at 5.0 
x 104 hDPSCs, COLL demonstrated significantly higher cell proliferation rates than cells 
in media only (control, p < 0.01) or cells co- incubated with PLGA (p < 0.01). In ELISA 
test, no significant differences were observed between cells with media only and COLL 
at 1, 3, and 6 days. Cells incubated with PLGA expressed significantly higher IL-8 than 
the control at all time points (p < 0.01) and compared to COLL after 1 and 3 days (p 
< 0.01). Conclusions: The COLL showed superior biocompatibility and thus may be 
suitable for endodontic regeneration purposes. (Restor Dent Endod 2016;41(2):98-105)
Key words: Clindamycin; Matrix; Metronidazole; Regenerative endodontics; 
Revascularization; Scaffold 
Introduction 
Root canal treatment is a highly successful procedure.1,2 However, the treatment of 
teeth with immature roots and pulp necrosis presents significant difficulties for the 
dental clinician in regard to disinfection and filling of the wide root canal space and 
open apex. For the practitioner, the revascularization of immature necrotic teeth has 
become an alternative to apexification techniques.
Current techniques involve disinfecting irrigation, placement of calcium hydroxide 
or an antibiotic paste as a temporary medication, and the instigation of a blood clot 
within the root canal space to establish the revascularization. Unfortunately, a blood 
clot is difficult to produce, unstable and therefore susceptible to breakdown. Moreover, 
it is a desirable substrate for microbes left behind in the root canal or reintroduced 
through reinfection from the oral cavity. While or immediately after setting, it is also 
difficult to seal with a coronal restoration.
To overcome some of the difficulties associated with an intracanal blood clot, the 
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use of scaffold materials was suggested. Examples of 
three-dimensional organic scaffolds include collagen,3-5 
glycosaminoglycan, fibrin, cell-sponge constructs or 
combinations thereof. Synthetic scaffolds are PCL (poly-
caprolactone),6 PEG (poly ethyleneglycol), PLA (poly-
lactic acid),5 PGA (poly-glycolic acid), PLGA (poly-lactic-
co-glycolic acid),7 or hydrogels. For endodontic purposes, 
scaffolds must provide an adequate porosity and pore 
size to allow pulp stem or progenitor cells to migrate 
and/or organize within a three-dimensional structure, 
be capable to support cell organization, neuro-, angio- 
or vasculogenesis and to provide necessary nutritional 
support.8,9
Collagen is a natural constituent of the dental pulp. 
Collagen scaffolds were shown to provide a suitable 
environment for pulp progenitor and adult stem cells with 
odontoblastic properties in vitro,10 and adequate new tissue 
development with rare histologic inflammation in vivo.11 
Cell seeded collagen scaffolds have been used in animals 
for in vivo pulp regeneration after pulpotomies,12 and 
after pulpectomies,13 demonstrating regeneration of pulp 
tissue with angio- and neurogenesis.12,13 Collagen and PLGA 
scaffolds also showed the regenerative capacity of swine 
dental pulp stem cells after reimplantation into minipig 
teeth.14 Development of dentin/pulp-like tissues was 
observed after subcutaneous implantation of rabbit dental 
pulp stem cells in PLGA scaffolds.15 PLGA was also used 
for growth factor or drug delivery, e.g. for pulp capping 
purposes containing TGF-β1 to initiate tertiary dentin 
formation,11 or as nanoparticles loaded with methylene blue 
to initiate photo-disinfecting action against Enterococcus 
faecalis.16
Antibiotic containing scaffold materials were suggested 
for pulpal regeneration.8 In periodontics, they were 
found to be suitable for guided tissue regeneration.17 
Metronidazole or ciprofloxacin releasing polydioxanone 
polymer nanofiber scaffolds were recently introduced for 
pulp regeneration.18-20 This study aimed to investigate the 
biocompatibility of two experimental antibiotic releasing 
scaffolds, based on either type-I collagen or on PLGA, with 
human dental pulp stem cells (hDPSCs) for the potential 
clinical use in revascularization or regeneration procedures.
Materials and Methods 
Scaffolds
One resilient lyophilized collagen (COLL) scaffold, 
releasing metronidazole and clindamycin, was compared 
to an experimental injectable PLGA scaffold, releasing 
clindamycin. COLL scaffold was prepared at the University 
of Pennsylvania. Using cooled pipettes, 3.0 mg/mL type 
I bovine collagen (Ultrapure bovine collagen solution, 
Sigma-Aldrich, St. Louis, MO, USA) was mixed on ice with 
9 mMol glucose (D-(+)-Glucose, Sigma-Aldrich), sterile 
×10 phosphate buffered saline (PBS, Sigma-Aldrich), 1 N 
sodium hydroxide (NaOH, Sigma-Aldrich), distilled water, 
10 mg/mL Metronidazole (Metronidazole, Sigma-Aldrich) 
and 25 mg/mL Clindamycin (Clindamycin, Sigma-Aldrich) to 
a final concentration of collagen 2.6 mg/mL. Two hundred 
microliter (μL) of the mixed solution were delivered each 
into one well of micro-well strips (Immuno Module Plate 
With PolySorp Surface, Thermo Fisher Scientific Inc., 
Waltham, MA, USA). The micro-well strips were then placed 
into an incubator for 30 minutes at 37℃ to allow gelation. 
Then, the collagen gels were cross-linked in a ultra-violet 
cross-linker (Stratalinker UV crosslinker 2400, Stratagene, 
La Jolla, CA, USA) for another 30 minutes. After the cross-
linking process, the collagen gel was frozen at - 80℃ for 
24 hours and finally lyophilized in a freeze-dryer (Labconco 
Freezone lyophilizer, Labconco, Kansas City, MO, USA) for 
12 hours until a solid and porous scaffold was observed. 
The PLGA scaffold was provided by Skywalk Pharmacy 
(Milwaukee, WI, USA). While the exact manufacture is not 
being disclosed, this experimental scaffold contained 7.2 
wt% Clindamycin, the remainder split between a liquid 
PLGA solution and N-Methyl-2-pyrrolidone (NMP), a solvent 
used in the pharmaceutical industry for the formulation 
of oral and transdermal drugs. The scaffold solidified on 
contact with moisture with a gel-like consistency. 
Cell culture 
hDPSCs were kindly provided by Dr. Sunday Akintoye 
(University of Pennsylvania School of Dental Medicine, 
Department of Oral Medicine). Cells were cultured in growth 
culture media consisting of α-modified minimum essential 
medium (α-MEM, GIBCO, Invitrogen, Carlsbad, CA, USA), 
supplemented with 20% fetal bovine serum (FBS, Equitech 
Bio, Kerville, TX, USA), 100 U/mL penicillin, 100 mg/mL 
streptomycin sulfate (GIBCO/BRL, Grand Island, NY, USA) 
and 2 mMol glutamine (GIBCO/BRL), and incubated in a 
humidified 5% CO2 atmosphere at 37℃. The growth media 
in the wells was changed every other day. Cells grown in 
medium only served as control group for all experiments. 
Light microscopy 
hDPSCs were seeded at a density of 5.0 x 104 cells/well 
in 12-well plates (Corning Inc., Corning, NY, USA). Three 
hours after plating, one piece of COLL scaffold from a 
micro-strip well or one drop of PLGA scaffold of similar 
size as the COLL scaffold was completely immersed in the 
cell media in co-incubation with the cells. When the cells 
reached 90 - 95% confluence, light microscopy pictures 
were taken at ×100 and ×200 magnifications using a light 
microscope (TMS-F microscope, Nikon Instruments, Melville, 
NY, USA). 
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MTT assay 
Actively proliferating hDPSCs were plated in 96-well plates 
at densities of 1.0 × 104, 2.5 × 104, and 5.0 × 104 per well. 
Three hours after plating, one piece of COLL scaffold or one 
drop of PLGA scaffold of the same dimensions as mentioned 
above was immersed in form of co-incubation. After 48 
hours of incubation, cell proliferation was assessed using 
the Colorimetric MTT Cell Survival and Proliferation Assay 
Kit (Millipore, Chemicon International Inc., Temecula, CA, 
USA) according to the manufacturer’s protocol. Briefly, MTT 
reagents were added and incubated for 4 hours. Then 100 
µL isopropanol with 0.04 N HCl was added to each well. 
After thorough mixing using a plate shaker for 10 minutes 
at room temperature, the scaffolds were carefully removed 
from the wells and a colorimetric analysis performed with a 
multiplate reader (Synergy HT, Biotek, Winooski, VT, USA) 
at 570 nm. A solution of growth media with isopropanol 
and HCl served as negative control. The optical density 
values were obtained from triplicate samples and the 
experiment was repeated twice. 
IL-8 ELISA test 
hDPSCs were seeded at a 5.0 × 104 cells per well density 
in 12-well plates. Similarly, 3 hours after plating, one 
piece of COLL scaffold or one drop of PLGA scaffold were 
immersed with the cells for co-incubation. Supernatants 
were collected after 24 hours (Day 1 samples), 72 hours 
(Day 3 samples), and 6 days (Day 6 samples), and 
subsequently stored at - 80℃ until use. The amount of 
IL-8 was measured by an enzyme-linked immunosorbent 
assay (ELISA) using the Human IL-8 ELISA Kit II (BD 
Leong DJX et al.
OptEIA, BD Biosciences, Bedford, MA, USA) according to 
the manufacturer’s instructions. Growth media served as a 
negative control. The absorbance was read at 450 nm in 
the multiplate reader for triplicate samples. The experiment 
was repeated twice. 
Statistical analysis 
Prism 6.0 software (GraphPad Software Inc., La Jolla, CA, 
USA) was used for statistical analysis. The results of the 
absorbance measured using multiplate reader were analyzed 
using two-way analysis of variance (ANOVA) and post hoc 
Bonferroni test for the type of scaffold, and cell number or 
time point. Statistical significance was accepted at p < 0.05. 
Results
Light microscopy 
The exposure of hDPSCs to the two different scaffold 
materials after 7 days in co-culture revealed major 
morphological differences. Figure 1 shows the comparison 
of representative cell appearances under the light 
microscope at ×100 and ×200. In general, hDPSCs in the 
COLL group appeared healthier, well stretched and attached 
to the cell culture plate. Cells grew in direct proximity 
to the COLL scaffold with identical healthy appearance 
as in other areas of the culture wells (Figures 1a - 1d). 
Cells in co-incubation with the PLGA scaffold frequently 
demonstrated signs of degeneration and apoptosis, 
in particular in proximity to the actual material. An 
abundance of cell debris and rounded cell morphologies 
suggested non-attachment. (Figures 1e - 1h). 
Figure 1. Comparison of representative cell appearances under the light microscope at ×100 and ×200. ‘S’ denotes 
scaffolds. (a - d) Cells grown in proximity to COLL scaffolds demonstrated a generally healthy appearance similar to 
other areas of the culture wells and controls (arrows 1); (e - f) Co-incubation with the PLGA scaffold often displayed 
signs of apoptosis and cell degeneration, particularly close to the actual material. Cell debris (arrow 2) and rounded cell 
morphologies (arrow 3) suggested non-attachment. COLL, lyophilized collagen; PLGA, poly-lactic-co-glycolic acid.
(a) (b) (c) (d)
(e) (f) (g) (h)
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MTT assay 
Table 1 and Figure 2 show the absorbance readings 
measured using the multiplate reader. Of the hDPSCs 
seeded at 3 different densities (1.0 × 104, 2.5 × 104, and 
5.0 × 104), with media only, COLL or PLGA scaffolds, at 
2.5 × 104 and 5.0 × 104 cell densities, COLL demonstrated 
significantly higher cell proliferation rates than cells in 
media only (control) (p < 0.05 and p < 0.01, respectively) 
or in co-incubation with PLGA (p < 0.05 and p < 0.01, 
respectively). The effect of the different cell numbers was 
not statistically significant.  
IL-8 ELISA test 
No significant differences were observed between cells with 
media only and COLL at 1, 3, and 6 days. Cells incubated 
with PLGA expressed significantly higher IL-8 than the 
control at all time points (p < 0.01) and compared to 
COLL after 1 and 3 days (p < 0.01, Table 2 and Figure 3). 
The effect of the different time points was found to be 
statistically significant (p < 0.001). 
Table 1. Absorbance readings for MTT assay of various cell numbers and types of scaffold
Cell number Control PLGA COLL p value*
1.0 x 104 0.0660 ± 0.0071 0.0675 ± 0.0007 0.0750 ± 0.0014 α = 0.285
2.5 x 104 0.0640 ± 0.0057 0.0610 ± 0.0057 0.0855 ± 0.0007 β = 0.002
5.0 x 104 0.0615 ± 0.0092 0.0675 ± 0.0078 0.0950 ± 0.0057
Mean ± SEM for N = 6 per condition. *p < 0.05, by 2-way ANOVA and Bonferroni post hoc test. There was no significant 
difference in absorbance readings depending on cell number (p = 0.285 [α]), but a statistically significant difference depending 
on scaffold type (p = 0.002 [β]). PLGA, poly-lactic-co-glycolic acid; COLL, lyophilized collagen.
Figure 2. MTT assay. Absorbance measured using a 
multiplate reader. hDPSCs were seeded at 3 different 
densities (1.0 x 104, 2.5 x 104, and 5.0 x 104) with media 
only (red), PLGA scaffold (blue) or COLL scaffold (green). 
Mean ± SEM for N = 6 per condition. *p < 0.05, by 2-way 
ANOVA and Bonferroni post hoc test. hDPSC, human dental 
pulp stem cells; PLGA, poly-lactic-co-glycolic acid; COLL, 
lyophilized collagen.
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Figure 3. IL-8 ELISA test. Absorbance measured using a 
multiplate reader at 3 different time points (Days 1, 3, 
and 6). hDPSCs were seeded at 5.0 x 104 cell density with 
media only (red), PLGA scaffold (blue) or COLL scaffold 
(green). Mean ± SEM for N = 6 per condition. *p < 0.05, 
by 2-way ANOVA and Bonferroni post hoc test. hDPSC, 
human dental pulp stem cells; PLGA, poly-lactic-co-
glycolic acid; COLL, lyophilized collagen.
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Table 2. Absorbance readings for IL-8 ELISA test of various time points and types of scaffold
Time Control PLGA COLL p value*
Day 1 3.887 ± 0.002 3.913 ± 0.005 3.886 ± 0.009 α = 0.001
Day 3 3.881 ± 0.003 3.909 ± 0.006 3.879 ± 0.011 β = 0.0001
Day 6 3.865 ± 0.010 3.893 ± 0.008 3.875 ± 0.012
Mean ± SEM for N = 6 per condition. *p < 0.05, by 2-way ANOVA and Bonferroni post hoc test. There was a statistically 
significant difference in absorbance readings depending on time point (p = 0.001 [α]) and scaffold type (p = 0.0001 [β]). PLGA, 
poly-lactic-co-glycolic acid; COLL, lyophilized collagen.
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Discussion 
To date, no final approach to clinical revascularization 
or a common strategy to achieve pulp regeneration has 
been agreed upon. While it was recognized that clinical 
revascularization does not provide pulp or pulp-like tissues, 
the clinical benefits of an ingrowth of vital tissue into a 
disinfected tooth with a history of pulp necrosis are greatly 
beneficial to the patient. Successful revascularization not 
only provides vitality, but also generates the formation 
of a closed apex and strengthens the tooth structure by 
thickening of the root walls, thus adding prevention from 
fracture. While a consensus seems to exist that complete 
regeneration of the pulp would involve exogenously 
introduced cells, as cell-free regeneration after complete 
loss of the dental pulp appears unlikely,21 it is still unclear, 
which types of cells, scaffold materials and bioactive 
factors would provide the greatest chances of successful 
regeneration. Thus, clinical revascularization remains the 
best strategy for a practitioner to treat immature teeth 
with pulp necrosis. However, creating a suitable blood 
clot remains a challenge in clinical practice and scaffold 
materials may prove an alternative for clinical practice.
This study investigated two different potential scaffolds 
containing antibiotics. In endodontics, local antibiotics 
were initially used as intracanal medication to aid in 
the disinfection of infected, pulpless teeth.22 However, 
this treatment fell into disfavor and was only re-
established with new techniques for revascularization 
to disinfect immature, necrotic teeth. A triple antibiotic 
paste consisting of metronidazole, ciprofloxacin and 
minocycline was introduced,23 and its efficacy to penetrate 
dentin demonstrated in vitro.24 Several case reports 
on revascularization using triple antibiotic paste were 
published.25,26 The effectiveness of in vivo disinfection was 
shown by Windley et al.27 Several clinical complications 
were described for revascularization procedures, including 
discolorations by minocycline. Cefaclor was suggested as 
replacement for minocycline.28,29 Another problem was the 
potential collapse of MTA into the fresh blood clot, which 
could be overcome by the additional placement of a solid 
resorbable collagen matrix to pack MTA against.28 
The placement of scaffolds for current revascularization 
and, possibly, future regeneration procedures could serve 
several purposes. For revascularization, it can provide 
stability placing a suitable material against the blood clot. 
For regeneration, a matrix can supply stem or progenitor 
cells to the root canal and provide support for the ingrowth 
of vascularization and re-innervation, as well as aid 
stability for early stages of tissue regeneration. For both 
procedures, a scaffold can provide bioactive substances.30
To use bioactive materials for the delivery of growth 
factors or drugs such as antibiotics in endodontic 
regenerative procedures was suggested earlier on.30,31 
Nevertheless, only few endodontic studies introduced 
growth factor,32,33 or antibiotic-containing scaffolds.18-20 
Bottino et al.18 used metronidazole or ciprofloxacin 
releasing nanofiber-scaffolds and tested them against 
Porphyromonas gingivalis and Enterococcus faecalis. In 
accordance with our study the metronidazole containing 
scaffolds demonstrated good cytocompatibil ity. 
Metronidazole inhibited only growth of Porphyromonas 
gingivalis, while ciprofloxacin was effective against both 
strains. This supports the idea of combining antibiotics to 
achieve a wider antibacterial spectrum, similar to triple 
antibiotic paste or the COLL scaffold in this investigation, 
combining metronidazole with clindamycin, a lincosamide, 
used to treat dental infections with anaerobic bacteria.34 
A commercially available triple antibiotic paste (PulpVAZ, 
Blaze Pharmaceuticals LLC, Ankeny, IA, USA) contains 
clindamycin as alternative to minocycline. Clindamycin 
demonstrated successful antibacterial activity as an 
intracanal dressing in vivo.35 In vitro, it showed significantly 
more antibacterial activity than tetracycline.36 Clindamycin 
releasing fibers from ethylene vinyl acetate significantly 
reduced bacteria in extracted human teeth and provided 
sustained antibiotic release of over 2 weeks.34 This 
surpassed the activity of metronidazole and ciprofloxacin 
for 48 hours.18 Even if not directly comparable, this 
substantial time difference suggests that clindamycin, if 
biologically acceptable, may be a good alternative for pulp 
regeneration. 
The present study evaluated biocompatibility and cell 
proliferation of hDPSCs with the experimental scaffolds. 
Although both scaffolds incorporated clindamycin, and 
both collagen and PLGA are known to be suitable scaffold 
materials for endodontic procedures, significant differences 
between the materials existed. Light microscopy permitted 
to observe cell morphology after co-incubation with 
the scaffolds. Cells in contact with the PLGA scaffolds 
frequently showed signs of degeneration and apoptosis. 
Whereas no significant difference in IL-8 concentration 
were found between hDPSCs cultured in media only and 
COLL, cells incubated with PLGA expressed significantly 
higher IL-8 than the control at all time points and 
compared to COLL after 1 and 3 days. This implied the 
induction of inflammation by the experimental PLGA 
scaffolds, suggesting less biocompatibility than the COLL 
scaffolds. 
Several factors may be responsible for the lower 
biocompatibility of the experimental PLGA scaffold. PLGA 
itself is biocompatible; however the experimental scaffold 
contained a very high percentage of NMP. This stabilizer, 
although widely used pharmaceutically may have adverse 
effects on hDPSCs. The concentration of the antibiotic 
component itself (7.2 wt%) may have influenced the 
biocompatibility. High concentrations of antibiotics in 
triple antibiotic paste of 1, 10, and 100 mg/mL resulted 
http://dx.doi.org/10.5395/rde.2016.41.2.98
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in significantly lower cell viability of stem cells from the 
apical papilla than concentrations of 0.1 and 0.01 mg/
mL or any concentration of calcium hydroxide.37 This may 
appear to be contradictory to the good biocompatibility 
of the experimental COLL scaffold containing 10 mg/
mL metronidazole and 25 mg/mL clindamycin. However, 
Chuensombat et al. demonstrated that the adverse cell 
viability effect of triple antibiotic paste, when tested 
against human dental pulp cells and apical papilla cells 
was related to minocycline and ciprofloxacin, whereas no 
significant differences between metronidazole and the 
control were found up to 25 mg/mL.38 Also, antibiotic-
containing scaffolds with 10 wt% metronidazole and 25 
wt% ciprofloxacin were successfully tested.18,19 
Although antibiotic use was suggested for regenerative 
procedures earlier,8 some studies advocated calcium 
hydroxide.37,39 However, calcium hydroxide itself may pose 
potential problems, including formation of a hard tissue 
barrier, or tooth structure weakening if applied too long.40 
Conclusions 
Within the limitations of this study, experimental resilient 
lyophilized metronidazole and clindamycin releasing 
collagen scaffolds could be of potential clinical use 
for revascularization or pulp regeneration procedures. 
Whereas further investigations including detailed material 
characterization, antimicrobial activity, and antibiotic 
substantivity are needed to validate the use of these 
scaffold materials, this pilot study demonstrated the 
biocompatibility and the effects on cell proliferation 
of antibiotic-releasing scaffolds in regenerative 
endodontics and gives the practitioner the insight of 
the potential application of scaffold materials useful 
for revascularization, which are cost-effective, easy 
to manipulate and would provide predictable positive 
outcomes for clinicians.
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